3624 results for «2473»

Filter By

3624 results

Valve-in-valve TAVI: session 1

27 Nov 2022 – From PCR London Valves 2022

ViV TAVI in a patient with previous Bentall's operation, ViV for a failed surgical aortic bioprosthesis with a misaligned mitral bioprosthesis, TAVI for severe aortic regurgitation caused by infective endocarditis after homograft surgery, and much more in this PCR LV 2022 session about ViV TAVI!

Valve-in-valve TAVI: session 1

Primary mitral regurgitation: treatment options when the anatomy is complex

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.

Primary mitral regurgitation: treatment options when the anatomy is complex

Rapid-fire abstracts: session 2

27 Nov 2022 – From PCR London Valves 2022

Take advantage of this PCR LV 2022 session to discover more abstracts and learn more about how to predict TAVI bicuspid aortic valve re-access, or right ventricle-pulmonary artery coupling in patients with severe aortic stenosis, among others.

Rapid-fire abstracts: session 2

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Top Late-Breaking Trials

CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.

Tricuspid - Late-Breaking Trials

TAVI is a mature procedure: implications for lifelong management of young and old patients

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about TAVI implications for lifelong management, to understand what is happening in the field of aortic valve intervention and to appreciate the evidence governing the application of this procedure in the lifetime journey of patients with aortic...

TAVI is a mature procedure: implications for lifelong management of young and old patients

Rapid-fire abstracts: session 3

27 Nov 2022 – From PCR London Valves 2022

Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.

Rapid-fire abstracts: session 3

Hot TAVI topics - Cerebral embolic protection

27 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the latest data concerning cerebral embolic protection (CEP) in TAVI, to find out about currently available and emerging embolic protection devices and to get a better understanding of variations in head and neck vessel anatomy and tips and tricks...

Hot TAVI topics - Cerebral embolic protection

Mitral valve in mitral annular calcification (MAC) - Recorded case

27 Nov 2022 – From PCR London Valves 2022

A 53-year-old male with a history of SAVR (Perimount 23) 10 years ago and chest radiotherapy (lymphoma) presents a severe mitral stenosis (MAC) with preserved LV function and impaired RV function.
On sentinel cerebral protection, the operators perform a transseptal puncture with electrifying a non-stiff guide wire,...

Recorded case: Mitral valve in MAC

The multidisciplinary structural heart team - How do we include the patient

27 Nov 2022 – From PCR London Valves 2022

Consult this session on the multidisciplinary structural heart team to learn more about the evolving role of the team and how this affects decision making, to discover why patient advocacy and partnership is vital within the team, as well as to identify potential barriers and enablers of the future...

The multidisciplinary structural heart team - How do we include the patient

TAVI: vascular access and bleeding complications

27 Nov 2022 – From PCR London Valves 2022

To learn more about FAST ACCESS Pilot, transfemoral-only TAVI, next-generation suture-mediated closure device in TAVR, or percutaneous axillary TAVI under local anaesthesia, among others, watch this session from PCR LV 2022!

TAVI: vascular access and bleeding complications

Paravalvular leak closure

27 Nov 2022 – From PCR London Valves 2022

5 specific cases are proposed in this PCR LV 2022 session dedicated to PVL, including concomitant ViV TAVI and paravalvular leak closure, transapical mitral paravalvular leak closure in a young patient, or transcatheter mitral ViV implantation for paravalvular leak. Watch the videos now to find out more!

Paravalvular leak closure

Tricuspid and pulmonary interventions

27 Nov 2022 – From PCR London Valves 2022

Watch this series of cases presented at PCR LV 2022 and learn more about Alagille syndrome, how to treat a significant right-to-left shunt after bicaval valve implantation, or analyze transcatheter pulmonary valve implantation in tetralogy of Fallot, among others.

Tricuspid and pulmonary interventions

TAVI: Late-Breaking Trials and Innovations

27 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!

TAVI: Late-Breaking Trials and Innovations

Rapid-fire abstracts: session 4

27 Nov 2022 – From PCR London Valves 2022

In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...

Rapid-fire abstracts: session 4

Patient selection for tricuspid valve interventions

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the anatomical assessment of candidates for transcatheter tricuspid valve interventions, to understand the importance of detailed haemodynamic assessment in patients with severe tricuspid regurgitation and to discuss the predictors of clinical outcome after these interventions.

Patient selection for tricuspid valve interventions

Is frailty still relevant after 20 years of TAVI?

28 Nov 2022 – From PCR London Valves 2022

Consult this session to gain further knowledge of the frailty syndrome, to understand its relevance in today's patient population and to learn how to measure it using validated tools.

Is frailty still relevant after 20 years of TAVI?

TAVI in complex situations - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI with the presence of a mechanical mitral valve.
    An 80-year-old female with a history of mechanical mitral valve (25 On-X in 2015) presents severe symptomatic AS with preserved LV function. The operators implant a 25 mm Navitor, with predilatation (18 mm balloon) on wire pacing...
Transcatheter intervention for aortic valve disease: state of the art

A case-based tailored approach to the treatment of mitral valve disease: the Heart Team ring

28 Nov 2022 – From PCR London Valves 2022

Join an advanced Heart Team in a real case discussion to understand what "mitral valve complexity" really means and to learn how to optimise selection between repair and replacement options.

A case-based tailored

Haemodynamic performance of transcatheter aortic valves: practical considerations for lifetime management

28 Nov 2022 – From PCR London Valves 2022

Watch this highly interactive session which focuses on the impact of haemodynamic performance on valve durability and patient survival, and how the design of bioprosthetic aortic valves influences clinical outcomes.

Haemodynamic performance
Didn’t find what you were looking for?